JP2023539136A5 - - Google Patents
Info
- Publication number
- JP2023539136A5 JP2023539136A5 JP2023512161A JP2023512161A JP2023539136A5 JP 2023539136 A5 JP2023539136 A5 JP 2023539136A5 JP 2023512161 A JP2023512161 A JP 2023512161A JP 2023512161 A JP2023512161 A JP 2023512161A JP 2023539136 A5 JP2023539136 A5 JP 2023539136A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- methyl
- pyridine
- pyrrolo
- methylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063067389P | 2020-08-19 | 2020-08-19 | |
| US63/067,389 | 2020-08-19 | ||
| PCT/US2021/046475 WO2022040293A1 (en) | 2020-08-19 | 2021-08-18 | Substituted heteroaryl compounds useful as inhibitors of tlr9 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023539136A JP2023539136A (ja) | 2023-09-13 |
| JP2023539136A5 true JP2023539136A5 (enExample) | 2024-08-26 |
Family
ID=77726550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512161A Pending JP2023539136A (ja) | 2020-08-19 | 2021-08-18 | Ｔｌｒ９阻害剤として有用な置換ヘテロアリール化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20230322770A1 (enExample) |
| EP (1) | EP4200015B1 (enExample) |
| JP (1) | JP2023539136A (enExample) |
| KR (1) | KR20230052930A (enExample) |
| CN (1) | CN115956077A (enExample) |
| AR (1) | AR123284A1 (enExample) |
| AU (1) | AU2021328362A1 (enExample) |
| BR (1) | BR112023002662A2 (enExample) |
| CA (1) | CA3189816A1 (enExample) |
| CL (1) | CL2023000428A1 (enExample) |
| CO (1) | CO2023001670A2 (enExample) |
| IL (1) | IL300696A (enExample) |
| MX (1) | MX2023001883A (enExample) |
| PE (1) | PE20231318A1 (enExample) |
| TW (1) | TW202227431A (enExample) |
| WO (1) | WO2022040293A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI887510B (zh) * | 2020-12-22 | 2025-06-21 | 美商基利科學股份有限公司 | 6-取代之吲哚化合物 |
| TWI838670B (zh) * | 2020-12-22 | 2024-04-11 | 美商基利科學股份有限公司 | 經取代之吲哚化合物 |
| TWI861488B (zh) | 2021-04-16 | 2024-11-11 | 美商基利科學股份有限公司 | 噻吩并吡咯化合物 |
| US12070455B2 (en) | 2021-09-10 | 2024-08-27 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| EP4479135A1 (en) * | 2022-02-18 | 2024-12-25 | Bristol-Myers Squibb Company | Substituted imidazopyridinyl compounds useful as inhibitors of tlr9 |
| KR20250109202A (ko) * | 2022-11-10 | 2025-07-16 | 브리스톨-마이어스 스큅 컴퍼니 | Tlr9의 억제제로서 유용한 치환된 벤즈이미다졸 화합물 |
| CN120152957A (zh) * | 2022-11-10 | 2025-06-13 | 百时美施贵宝公司 | 用作tlr9抑制剂的经取代的喹诺酮 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130158049A1 (en) * | 2011-12-20 | 2013-06-20 | Hoffmann-La Roche Inc. | 7-azaindole inhibitors of crac |
| CA2933466A1 (en) * | 2013-12-13 | 2015-06-18 | Takeda Pharmaceutical Company Limited | Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors |
| AR103232A1 (es) * | 2014-12-22 | 2017-04-26 | Bristol Myers Squibb Co | ANTAGONISTAS DE TGFbR |
| JP7289301B2 (ja) * | 2017-12-18 | 2023-06-09 | ブリストル－マイヤーズ スクイブ カンパニー | ４－アザインドール化合物 |
| SG11202005704RA (en) * | 2017-12-19 | 2020-07-29 | Bristol Myers Squibb Co | 6-azaindole compounds |
| KR102730859B1 (ko) * | 2017-12-20 | 2024-11-15 | 브리스톨-마이어스 스큅 컴퍼니 | 아릴 및 헤테로아릴 치환된 인돌 화합물 |
-
2021
- 2021-08-18 MX MX2023001883A patent/MX2023001883A/es unknown
- 2021-08-18 AU AU2021328362A patent/AU2021328362A1/en not_active Abandoned
- 2021-08-18 IL IL300696A patent/IL300696A/en unknown
- 2021-08-18 PE PE2023000276A patent/PE20231318A1/es unknown
- 2021-08-18 CA CA3189816A patent/CA3189816A1/en active Pending
- 2021-08-18 JP JP2023512161A patent/JP2023539136A/ja active Pending
- 2021-08-18 BR BR112023002662A patent/BR112023002662A2/pt unknown
- 2021-08-18 KR KR1020237009018A patent/KR20230052930A/ko active Pending
- 2021-08-18 US US18/042,018 patent/US20230322770A1/en active Pending
- 2021-08-18 EP EP21769573.3A patent/EP4200015B1/en active Active
- 2021-08-18 TW TW110130426A patent/TW202227431A/zh unknown
- 2021-08-18 WO PCT/US2021/046475 patent/WO2022040293A1/en not_active Ceased
- 2021-08-18 AR ARP210102328A patent/AR123284A1/es not_active Application Discontinuation
- 2021-08-18 CN CN202180050343.7A patent/CN115956077A/zh active Pending
-
2023
- 2023-02-10 CL CL2023000428A patent/CL2023000428A1/es unknown
- 2023-02-15 CO CONC2023/0001670A patent/CO2023001670A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538608A5 (enExample) | ||
| JP4814783B2 (ja) | ピラゾロピリジン誘導体 | |
| RU2610262C2 (ru) | ХИНОЛИНКАРБОКСАМИДНЫЕ И ХИНОЛИНКАРБОНИТРИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ mGLuR2-НЕГАТИВНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ, КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ | |
| JP2022531801A5 (enExample) | ||
| RU2481333C2 (ru) | Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана | |
| JP2022552324A5 (enExample) | ||
| JP2012525395A5 (enExample) | ||
| RU2018112237A (ru) | Новые бициклические соединения в качестве дуальных ингибиторов atx/ca | |
| EA032609B1 (ru) | Соединения аминопиримидинила в качестве ингибиторов jak | |
| IL274816B1 (en) | The heteroaryl compounds are substituted with sulfone-pyridine alkyl amides | |
| CN104725356B (zh) | 氮杂环衍生物及其在药物中的应用 | |
| JP2013539777A5 (enExample) | ||
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| HRP20192323T1 (hr) | Novi derivati dihidrokinolin-2-ona | |
| RU2014120374A (ru) | Имидазопиридазины | |
| JP2023021316A (ja) | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 | |
| JP2021523177A5 (enExample) | ||
| JP2020503302A5 (enExample) | ||
| IL300696A (en) | ALTERNATIVE HETEROARYL COMPOUNDS ARE USEFUL AS TLR9 INHIBITORS | |
| JP2011519891A5 (enExample) | ||
| JP2022505707A5 (enExample) | ||
| JP2021501183A5 (enExample) | ||
| JP2022534434A5 (enExample) | ||
| JP2023538393A5 (enExample) | ||
| US9133160B2 (en) | Substituted benzimidazole and imidazopyridine compounds useful as CYP17 modulators |